BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$615M |
| 2 |
State Street SPDR S&P Retail ETF
XRT
|
+$231M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$229M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$186M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$136M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$620M |
| 3 |
Tesla
TSLA
|
+$594M |
| 4 |
Apple
AAPL
|
+$541M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$372M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.24% |
| 2 | Financials | 6.85% |
| 3 | Healthcare | 5.31% |
| 4 | Consumer Discretionary | 4.97% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Tucows
TCX
$134M
| $139K | ﹤0.01% |
1,758
+1,426
| +430% | +$110K |
|
|
LAND
3027
Gladstone Land Corp
LAND
$358M
| $138K | ﹤0.01% |
6,069
+5,128
| +545% | +$120K |
|
|
OLP
3028
One Liberty Properties
OLP
$537M
| $138K | ﹤0.01% |
4,520
+2,269
| +101% | +$69.2K |
|
|
CPRX
3029
DELISTED
Catalyst Pharmaceutical
CPRX
| $137K | ﹤0.01% |
25,837
+11,391
| +79% | +$62.3K |
|
3030
CRA International
CRAI
$1.07B
| $136K | ﹤0.01% |
1,370
+1,116
| +439% | +$101K |
|
3031
AnaptysBio
ANAB
$1.66B
| $136K | ﹤0.01% |
5,009
+2,222
| +80% | +$56.4K |
|
3032
Armstrong World Industries
AWI
$7.68B
| $136K | ﹤0.01% |
1,421
+633
| +80% | +$66.3K |
|
3033
Ocular Therapeutix
OCUL
$2.22B
| $136K | ﹤0.01% |
13,560
+10,714
| +376% | +$120K |
|
|
STEL
3034
DELISTED
Stellar Bancorp
STEL
| $135K | ﹤0.01% |
5,113
+2,731
| +115% | +$72.4K |
|
3035
Titan Machinery
TITN
$420M
| $135K | ﹤0.01% |
5,197
+2,219
| +75% | +$62.3K |
|
|
REVG
3036
DELISTED
REV Group
REVG
| $135K | ﹤0.01% |
7,841
+4,715
| +151% | +$75.1K |
|
3037
Luxfer Holdings
LXFR
$457M
| $133K | ﹤0.01% |
6,778
+5,561
| +457% | +$115K |
|
3038
Thomson Reuters
TRI
$46B
| $133K | ﹤0.01% |
1,139
-138
| -11% | -$16.1K |
|
3039
Independent Bank Corp
IBCP
$854M
| $132K | ﹤0.01% |
6,166
+2,852
| +86% | +$59.3K |
|
3040
Arrow Financial
AROW
$723M
| $132K | ﹤0.01% |
4,088
+1,932
| +90% | +$63.4K |
|
3041
Republic Bancorp
RBCAA
$1.92B
| $132K | ﹤0.01% |
2,611
+1,172
| +81% | +$57.4K |
|
|
CTT
3042
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $131K | ﹤0.01% |
11,065
+9,049
| +449% | +$105K |
|
3043
CRISPR Therapeutics
CRSP
$5.22B
| $131K | ﹤0.01% |
1,173
+13
| +1% | +$1.63K |
|
|
NESR
3044
National Energy Services Reunited Corp
NESR
$3.62B
| $131K | ﹤0.01% |
10,468
+5,816
| +125% | +$70.8K |
|
3045
Bank First Corp
BFC
$1.76B
| $131K | ﹤0.01% |
1,849
+909
| +97% | +$63.3K |
|
3046
CALL
Consolidated Edison
ED
$40.1B
| $131K | ﹤0.01% |
18
| – | – |
|
|
FLIC
3047
DELISTED
First of Long Island Corp
FLIC
| $130K | ﹤0.01% |
6,334
+3,235
| +104% | +$68K |
|
3048
VSE Corp
VSEC
$6.48B
| $130K | ﹤0.01% |
2,700
+1,267
| +88% | +$61.6K |
|
3049
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.8B
| $130K | ﹤0.01% |
+4,154
| New | +$130K |
|
|
SLNO
3050
DELISTED
Soleno Therapeutics
SLNO
| $130K | ﹤0.01% |
9,356
+5
| +0.1% | +$70 |
|
Similar funds
BNP Paribas Financial Markets's Q3 2021 Portfolio in Review
As of Q3 2021, BNP Paribas Financial Markets held 4,161 positions worth $70.6B, down 6.6% from $75.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
BNP Paribas Financial Markets withdrew a net $10.5B in Q3 2021, closing 150 positions and reducing 1,194 holdings. Its most notable exit was GE Aerospace, an estimated $147M position sold in full.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in iShares 10+ Year Investment Grade Corporate Bond ETF worth $5.86M.
- BNP Paribas Financial Markets's largest Q3 2021 buy was iShares 10+ Year Investment Grade Corporate Bond ETF: 84,600 shares worth $5.86M.
- BNP Paribas Financial Markets added most to iShares Russell 2000 ETF in Q3 2021, an estimated $615M increase.
- BNP Paribas Financial Markets's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.24B.
- BNP Paribas Financial Markets fully exited GE Aerospace in Q3 2021, selling an estimated $147M.
- BNP Paribas Financial Markets's ten largest holdings make up 14% of its $70.6B portfolio in Q3 2021.
- BNP Paribas Financial Markets opened 102 new positions and closed 150 in Q3 2021.
- BNP Paribas Financial Markets's portfolio value fell 6.6% quarter-over-quarter to $70.6B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2021, filed 12 Nov 2021.